KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) Other Operating Expenses (2016 - 2019)

Insulet filings provide 10 years of Other Operating Expenses readings, the most recent being -$135.0 million for Q4 2019.

  • On a quarterly basis, Other Operating Expenses fell 27.83% to -$135.0 million in Q4 2019 year-over-year; TTM through Sep 2020 was -$135.0 million, a 559.26% decrease, with the full-year FY2017 number at $124.2 million, up 31.45% from a year prior.
  • Other Operating Expenses hit -$135.0 million in Q4 2019 for Insulet, down from $47.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $47.2 million in Q3 2019 to a low of -$135.0 million in Q4 2019.
  • Median Other Operating Expenses over the past 5 years was $26.7 million (2016), compared with a mean of $14.9 million.
  • Biggest five-year swings in Other Operating Expenses: surged 226.11% in 2015 and later tumbled 378.48% in 2018.
  • Insulet's Other Operating Expenses stood at $23.4 million in 2015, then grew by 8.48% to $25.4 million in 2016, then skyrocketed by 49.47% to $37.9 million in 2017, then tumbled by 378.48% to -$105.6 million in 2018, then fell by 27.83% to -$135.0 million in 2019.
  • The last three reported values for Other Operating Expenses were -$135.0 million (Q4 2019), $47.2 million (Q3 2019), and $46.7 million (Q2 2019) per Business Quant data.